|  Help  |  About  |  Contact Us

Publication : The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.

First Author  Webb CF Year  2000
Journal  J Immunol Volume  165
Issue  12 Pages  6956-65
PubMed ID  11120822 Mgi Jnum  J:118397
Mgi Id  MGI:3699534 Doi  10.4049/jimmunol.165.12.6956
Citation  Webb CF, et al. (2000) The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J Immunol 165(12):6956-65
abstractText  Binding of the transcription factor Bright to Ig heavy chain loci after B cell activation is associated with increased heavy chain transcription. We now report that Bright coprecipitates with Bruton's tyrosine kinase (Btk), the defective enzyme in X-linked immunodeficiency disease (xid). Furthermore, we observed Btk in the nucleus of activated murine B cells, and mobility shift assays suggest that it is a component of the Bright DNA-binding complex. While BRIGHT protein was synthesized in activated spleen cells from xid mice, it did not bind DNA or associate stably with Btk. These data suggest that deficiencies in BRIGHT DNA-binding activity may contribute to the defects in Ig production seen in xid mice.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

Trail: Publication

0 Expression